GlassScriptPhysician profile
Stephanie Pearson
NPI 1003109091
$3,956.34
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,075 · 2020: $410 · 2021: $647 · 2022: $367 · 2023: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $441 · Education: $16.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $440.91 |
| Education | $16.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $959.92 | 2019-2020 | |
| Medtronic USA, INC. | $771.00 | 2019-2020 | |
| Nevro Corp. | $361.79 | 2019-2023 | Senza |
| Scilex Pharmaceuticals INC. | $306.20 | 2021-2023 | Ztlido |
| Abbott Laboratories | $279.87 | 2019-2022 | |
| Pacira Therapeutics, INC. | $250.61 | 2019-2021 | |
| Amgen INC. | $196.89 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $180.91 | 2019-2020 | |
| Si-Bone, INC. | $136.61 | 2021 | |
| Aesculap Implant Systems, LLC | $119.29 | 2022 | |
| Novartis Pharmaceuticals Corporation | $92.53 | 2019 | |
| Abbvie INC. | $69.70 | 2023 | |
| Medtronic, INC. | $59.03 | 2021-2022 | |
| Relievant Medsystems, INC. | $37.68 | 2021-2023 | Intracept |
| Ibsa Pharma INC. | $35.82 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $34.45 | 2019-2023 | Tymlos |
| Curonix LLC | $32.08 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Orthofix Medical, INC. | $16.59 | 2023 | Spinal-Stim, Spinal-Stim |
| Pacira Pharmaceuticals Incorporated | $15.37 | 2023 | Zilretta, Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Pearson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.